Sumitomo Dainippon Pharma Co's total assets for Q1 2026 were ¥733.33B, a decrease of -1.25% from the previous quarter. JP:4506 total liabilities were ¥557.10B for the fiscal quarter, a -2.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.